Dexcom (DXCM) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.34% |
| Dec 31, 2025 | 5.55% |
| Sep 30, 2025 | 15.25% |
| Jun 30, 2025 | 11.98% |
| Mar 31, 2025 | 10.11% |
| Dec 31, 2024 | 9.54% |
| Sep 30, 2024 | 9.98% |
| Jun 30, 2024 | 14.72% |
| Mar 31, 2024 | 13.87% |
| Dec 31, 2023 | 13.45% |
| Sep 30, 2023 | 19.83% |
| Jun 30, 2023 | 24.65% |
| Mar 31, 2023 | 31.10% |
| Dec 31, 2022 | 31.06% |
| Sep 30, 2022 | 30.87% |
| Jun 30, 2022 | 36.18% |
| Mar 31, 2022 | 36.83% |
| Dec 31, 2021 | 37.06% |
| Sep 30, 2021 | 62.44% |
| Jun 30, 2021 | 64.73% |
| Mar 31, 2021 | 69.79% |
| Dec 31, 2020 | 68.05% |
| Sep 30, 2020 | 65.68% |
| Jun 30, 2020 | 64.19% |
| Mar 31, 2020 | 73.69% |
| Dec 31, 2019 | 81.16% |
| Sep 30, 2019 | 82.11% |
| Jun 30, 2019 | 83.78% |
| Mar 31, 2019 | 87.51% |
| Dec 31, 2018 | 87.21% |
| Sep 30, 2018 | 63.13% |
| Jun 30, 2018 | 66.47% |
| Mar 31, 2018 | 67.95% |
| Dec 31, 2017 | 69.82% |
| Sep 30, 2017 | 74.22% |
| Jun 30, 2017 | 78.58% |
| Mar 31, 2017 | 55.23% |
| Dec 31, 2016 | 48.70% |
| Sep 30, 2016 | 48.68% |
| Jun 30, 2016 | 48.17% |
| Mar 31, 2016 | 44.71% |
| Dec 31, 2015 | 40.18% |
| Sep 30, 2015 | 35.67% |
| Jun 30, 2015 | 25.49% |
| Mar 31, 2015 | 17.08% |
| Dec 31, 2014 | 15.28% |
| Sep 30, 2014 | 7.37% |
| Jun 30, 2014 | 0.81% |
| Dec 31, 2013 | 16.66% |